Showing results (631-640 of 9,607) with videos related to
Sort By:
Pageof 961
Clinical Rheumatology|June 20, 2021
Hepcidin in Kawasaki disease: upregulation by acute inflammation in patients having resistance to intravenous immunoglobulin therapyTakashi Ishikawa, Yasuyuki Wada, Hiroyuki Namba, et al.Clinical Rheumatology|June 22, 2021
Quantification of bone marrow edema in rheumatoid arthritis by using high-speed T2-corrected multiecho acquisition of 1H magnetic resonance spectroscopy: a feasibility studyWenzhao Yuan, Yiwu Lei, Cheng Tang, et al.Clinical Rheumatology|July 2, 2021
Platelet distribution width is highly associated with thrombotic events in primary antiphospholipid syndromeYu Shi, Hui Jiang, Can Huang, et al.Clinical Rheumatology|July 3, 2021
A bibliometric analysis of rheumatology and COVID-19 researchesOzge Pasin, Tugce PasinClinical Rheumatology|July 4, 2021
Antimalarial drugs-are they beneficial in rheumatic and viral diseases?-considerations in COVID-19 pandemicBogna Grygiel-GórniakClinical Rheumatology|July 5, 2021
Identification of differential key biomarkers in the synovial tissue between rheumatoid arthritis and osteoarthritis using bioinformatics analysisRunrun Zhang, Xinpeng Zhou, Yehua Jin, et al.Clinical Rheumatology|June 12, 2021
Serum cartilage oligomeric matrix protein is correlated with quantitative magnetic resonance imaging and arthroscopic cartilage findings in anterior cruciate ligament deficient knees without osteoarthritic changesYohei Nishida, Yusuke Hashimoto, Kumi Orita, et al.Clinical Rheumatology|May 26, 2022
Elevated CXCL13 in primary Sjögren's syndrome and its correlation with disease activity: a systematic review and meta-analysisTong Zhu, Zijian Pan, Nannan ZhangClinical Rheumatology|May 26, 2022
Absence of association between nailfold capillary findings and mild cognitive dysfunction in systemic lupus erythematosusPamela Munguía-Realpozo, Mario García-Carrasco, Claudia Mendoza-Pinto, et al.Clinical Rheumatology|June 17, 2021
Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life studyMariagrazia Lorenzin, Augusta Ortolan, Giacomo Cozzi, et al.Pageof 961